Details for New Drug Application (NDA): 021713
✉ Email this page to a colleague
The generic ingredient in ABILIFY is aripiprazole. There are forty-nine drug master file entries for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the aripiprazole profile page.
Summary for 021713
Tradename: | ABILIFY |
Applicant: | Otsuka |
Ingredient: | aripiprazole |
Patents: | 1 |
Medical Subject Heading (MeSH) Categories for 021713
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;ORAL | Strength | 1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Dec 10, 2004 | TE: | RLD: | Yes | |||||
Patent: | ⤷ Sign Up | Patent Expiration: | Mar 2, 2027 | Product Flag? | Substance Flag? | Delist Request? | |||
Patented Use: | ADJUNCTIVE TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD) |
Expired US Patents for NDA 021713
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Otsuka | ABILIFY | aripiprazole | SOLUTION;ORAL | 021713-001 | Dec 10, 2004 | ⤷ Sign Up | ⤷ Sign Up |
Otsuka | ABILIFY | aripiprazole | SOLUTION;ORAL | 021713-001 | Dec 10, 2004 | ⤷ Sign Up | ⤷ Sign Up |
Otsuka | ABILIFY | aripiprazole | SOLUTION;ORAL | 021713-001 | Dec 10, 2004 | ⤷ Sign Up | ⤷ Sign Up |
Otsuka | ABILIFY | aripiprazole | SOLUTION;ORAL | 021713-001 | Dec 10, 2004 | ⤷ Sign Up | ⤷ Sign Up |
Otsuka | ABILIFY | aripiprazole | SOLUTION;ORAL | 021713-001 | Dec 10, 2004 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription